CAS 1630160-25-6

1,3,4-Oxadiazole, 2-(4-chlorophenyl)-5-[[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]thio]-

Description:

1,3,4-Oxadiazole, 2-(4-chlorophenyl)-5-[[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]thio]- is a heterocyclic compound featuring a fused oxadiazole and triazole structure, which contributes to its potential biological activity. The presence of the 4-chlorophenyl group enhances its lipophilicity, potentially improving its ability to penetrate biological membranes. The thioether linkage in the molecule may influence its reactivity and interactions with biological targets. This compound is of interest in medicinal chemistry due to its potential applications in pharmaceuticals, particularly as an antimicrobial or anticancer agent. Its unique structural features allow for diverse interactions with biological macromolecules, making it a candidate for further research in drug development. Additionally, the compound's stability, solubility, and overall pharmacokinetic properties would be critical factors in determining its viability as a therapeutic agent. As with many synthetic compounds, safety and toxicity assessments are essential for evaluating its suitability for use in clinical settings.

Formula: C₁₇H₁₂ClN₅OS

Synonyms:

• 1,3,4-Oxadiazole, 2-(4-chlorophenyl)-5-[[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]thio]-

ML338

CAS: 1630160-25-6

ML338 is a potent inhibitor of dormant M. tuberculosis with IC90 of 1 μM and IC99 of 4 μM, aiding in tuberculosis research.

Formula: C₁₇H₁₂ClN₅OS

Color and Shape: Solid

Molecular weight: 369.83

Ref: TM-T39109